Drug
Peg 4000
Peg 4000: highest development phase Post-Market, developed by Ipsen. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Ipsen
Trials
| Drug | Phase | Indication |
|---|---|---|
| PEG 4000 (Forlax ®) NCT00276354 | Post-Market | Constipation |
Latest
No recent events.
Follow Peg 4000 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.